This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Andrea Imle, PhD
Associate Director at BioNTech SE
Speaker

Profile

Andrea is an Associate Director in the Immunotherapies and Preclinical Research Department at BioNTech SE in Mainz, Germany. Andrea holds a MSc in Biomedicine and did her PhD at the University of Heidelberg (Germany) investigating the interplay between T cell motility and HIV cell-to-cell spread. Her postdoc research at the EMBL (European Molecular Biology Laboratory) focused on T cell migration in dense environments as found in solid tumors. Upon joining BioNTech SE in 2021, she has been working on enhancing anti-tumor immune responses with immunomodulatory antibodies. She has contributed to several IND filings and within her team aims to elucidate the mechanisms of action of single and combination antibody therapies.

Agenda Sessions

  • DuoBody-EpCAMx4-1BB Facilitates Conditional T-cell Co-stimulation and Augments Antitumor Activity in Preclinical Studies

    8:15am